GFACX | VILSX | GFACX / VILSX | |
Total Expense Ratio | 1.36 | 0.89 | 153% |
Annual Report Gross Expense Ratio | 1.36 | 1.03 | 132% |
Fund Existence | 25 years | 5 years | - |
Gain YTD | 17.268 | 0.285 | 6,063% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 336B | 391M | 85,934% |
Annual Yield % from dividends | 0.00 | 0.33 | - |
Returns for 1 year | 9.41 | -13.29 | -71% |
Returns for 3 years | 64.76 | 15.22 | 426% |
Returns for 5 years | 30.67 | -23.27 | -132% |
Returns for 10 years | 80.65 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
GMVAX | 16.47 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
CLBFX | 38.87 | 0.04 | +0.10% |
American Funds American Balanced 529F | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst | |||
TAISX | 13.83 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq I |